← Back to Intel
Insider ActivityINTS
BENDER LEWIS H, President and CEO, Director at INTENSITY THERAPEUTICS, INC., traded $231K of INTS
Updated Jun 13, 2026
BENDER LEWIS H
President and CEO, Director
INTENSITY THERAPEUTICS, INC. ·
$INTS
Transaction Details
| Insider | BENDER LEWIS H |
|---|---|
| Title | President and CEO, Director |
| Company | INTENSITY THERAPEUTICS, INC. |
| Ticker | INTS |
| Transaction Type | Grant |
| Transaction Date | 2026-03-26 |
| Shares Traded | 37,749 |
| Price Per Share | $6.11 |
| Total Value | $231K |
| Filed Date | 2026-03-30 |
| Accession Number | 0001238705-26-000005 |
Ownership Context
| Shares Owned After Transaction | 118,549 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001238705-26-000005
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for INTS — INTENSITY THERAPEUTICS, INC. →
Track INTS insider activity in real time on The Wire →
Get alerts when BENDER LEWIS H files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 13, 2026 at 07:20 UTC